pembrolizumab
merck
['keynote-412']
results of the keynote-412 at #esmo22. the needle is yet to move for locally advanced h&amp;n cancer patients. but what about those with high pdl1 status? 
Radiation Oncologist | RTQA Fellow @EORTC | SF&Fantasy Reader | Wannabe Movie Connoiseur |